---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286951564.md"
description: "Enveric Biosciences shares are trading lower. The company announced preclinical in vitro results showing no photoreactive potential for EB‑003, further derisking its neuropsychiatric program."
datetime: "2026-05-19T17:34:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286951564.md)
  - [en](https://longbridge.com/en/news/286951564.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286951564.md)
---

# 

Enveric Biosciences shares are trading lower. The company announced preclinical in vitro results showing no photoreactive potential for EB‑003, further derisking its neuropsychiatric program.

### Related Stocks

- [ENVB.US](https://longbridge.com/en/quote/ENVB.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)

## Related News & Research

- [Enveric Biosciences Q2 net loss widens](https://longbridge.com/en/news/295971436.md)
- [Enveric Biosciences says preclinical GloSensor assay supports non-hallucinogenic profile for EB-003](https://longbridge.com/en/news/294962761.md)
- [Enveric Biosciences Says New Preclinical Data Confirms Non-Hallucinogenic Profile For Lead Psychiatric Candidate](https://longbridge.com/en/news/294976532.md)
- [Enveric welcomes final FDA guidance on psychedelic drug trials](https://longbridge.com/en/news/294062160.md)
- [Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2025 | ENVB Stock News](https://longbridge.com/en/news/280850094.md)